MIRA INFORM REPORT

 

 

Report No. :

352175

Report Date :

01.12.2015

 

IDENTIFICATION DETAILS

 

Name :

THYROCARE TECHNOLOGIES LIMITED

 

 

Registered Office :

D-37/1, TTC Industrial Area, MIDC, Turbhe, Navi Mumbai – 400703, Maharashtra

Tel. No.:

91-22-67123456 / 41252525 / 30900000

 

 

Country :

India

 

 

Financials (as on) :

31.03.2014

 

 

Date of Incorporation :

28.01.2000

 

 

Com. Reg. No.:

11-123882

 

 

Capital Investment / Paid-up Capital :

Rs.109.180 Million

 

 

CIN No.:

[Company Identification No.]

U85110MH2000PLC123882

 

 

IEC No.:

0301031533

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

MUMT07390F

 

 

PAN No.:

[Permanent Account No.]

AABCT2577P

 

 

Legal Form :

A Closely Held Public Limited Liability Company

 

 

Line of Business :

Subject is engaged into providing diagnostic services.

 

 

No. of Employees :

1000 (Approximately)

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba (51)

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Status :

Satisfactory

 

 

Payment Behaviour :

Regular

 

 

Litigation :

Clear

 

 

Comments :

Subject is as well-known company incorporated in the year 2000 having satisfactory track.

 

Rating takes into consideration the strong financial risk profile marked by strong networth base along with minimal debt level in FY14.

 

The company has reported significant increase in its sales turnover along with decent profit margin. Overall financial position of the company is decent.

 

Trade relations are fair. Business is active and payment terms are regular and as per expectations.

 

In a view of strong financial conditions, the company can be considered for business dealings with usual trade terms and conditions.

 

NOTES:

Any query related to this report can be made on e-mail: infodept@mirainform.com while quoting report number, name and date.

 


 

EXTERNAL AGENCY RATING

 

NOT AVAILABLE

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2015.

 

INFORMATION PARTED BY

 

Name :

Mr. Aditya Shinde

Designation :

Account Manager

Contact No.:

91-22-41252525

Date :

28.11.2015

 

 

LOCATIONS

 

Registered / Head Office :

D-37/1, TTC Industrial Area, MIDC, Turbhe, Navi Mumbai – 400703, Maharashtra, India

Tel. No.:

91-22-67123456 / 41252525 / 30900000

Fax No.:

91-22-27682409

E-Mail :

info@thyrocare.com

asr@thyrocare.com

Website :

www.thyrocare.com

Area :

5000 Sq. Ft. (Approximately)

Location :

Owned

Locality :

Industrial

 

 

DIRECTORS

 

As on 21.08.2014

 

Name :

Velumani Arokiaswamy

Designation :

Managing Director

Address :

D-37/1 TTC MIDC, Next to Allana Cold Storage, Vashi, Navi Mumbai - 400703, Maharashtra, India

Date of Birth/Age :

25.04.1958

Date of Appointment :

01.04.2014

DIN No.:

00002804

 

 

Name :

Sumathi Velumani Naidu

Designation :

Director

Address :

C/O. Of Thyrocare, D-37/1, TTC MIDC Industries, Navi Mumbai - 400705, Maharashtra, India

Date of Birth/Age :

17.12.1960

Date of Appointment :

01.07.2013

DIN No.:

00002812

 

 

Name :

Sundararaju Aarogiasamy Naidu

Designation :

Whole-Time Director

Address :

A-02, 01, Crimson Dawn Pricol Apartment, Nava India Road, Peelamedu, Coimbatore - 641004, Tamilnadu, India

Date of Birth/Age :

04.09.1958

Date of Appointment :

01.04.2014

DIN No.:

00003260

 

 

Name :

Mr. Gopal Shivram Hegde

Designation :

Director

Address :

134, Aram Nagar II, Versova Road, Andheri (West), Mumbai - 400061, Maharashtra, India

Date of Birth/Age :

16.06.1959

Date of Appointment :

21.08.2014

DIN No.:

00157676

 

 

Name :

Sohil Chand

Designation :

Nominee Director

Address :

B 19 Defence Colony, New Delhi - 110024, India

Date of Birth/Age :

13.04.1978

Date of Appointment :

27.09.2013

DIN No.:

02170052

 

 

Name :

Neetin Shivajirao Desai

Designation :

Director

Address :

B-19/6 Kendriya Vihar Setcor 11, Khar Ghar Panvel Raigad, Panvel Navi Mumbai - 410210, Maharashtra, India

Date of Appointment :

20.09.2014

DIN No.:

02622364

 

 

Name :

Mr. Vishwas Madhav Kulkarni

Designation :

Director

Address :

B 504, 5th Floor, Raunak Tower, Off Gokhale Road, Naupda, Thane (West), Mumbai - 400602, Maharashtra, India

Date of Birth/Age :

06.05.1961

Date of Appointment :

21.08.2014

DIN No.:

06953750

 

 

Name :

Mr. Narayanasamy Palanisamy

Designation :

Director

Address :

4/7, Savithri Agrden, Chinthamani Pudur, Irugur, Coimbatore - 641103, Tamil Nadu, India

Date of Appointment :

20.09.2014

DIN No.:

06972368

 

 

KEY EXECUTIVES

 

Name :

Mr. Ramjee Dorai

Designation :

Company Secretary

Address :

B-503, Pride Residency, Sector 7, Near Hiranandani, Kharghar, Navi Mumbai - 410210, Maharashtra, India

Date of Appointment :

03.09.2014

PAN No.:

ADDPR1630D

 

 

MAJOR SHAREHOLDERS

 

As on 21.08.2014

 

Names of Shareholders

No. of Shares

A. Velumani

1849479

V. Sumathi

130712

V. Anand

197848

V. Amruta

170712

A. Velumani HUF

198324

A. Sundararaju HUF

649135

S. Bhamini

1000

A. Sundararaju

20812

A. Rathinaswamy

1000

R. Vasanthamani

1000

A. Rathinaswamy HUF

1000

S. Susila

1000

K. Selvaraj

1000

P. Arokiaswamy

1001

A. Sayammal

1001

Rao Rajgopal J.K.

1000

Mahima Advertising Private Limited, India

315000

Thyrocate Properties and Infra Private Limited, India

1304450

Norwest Venture partners VII-A, Mauritius

1266220

Sumathi Infra Project Private Limited, India

221280

Thyrocare Publications Private Limited, India

1633625

Bennett Coleman and Company, India

75000

Agalia Private Limited, Mauritius

2363050

Samara Capital Partners Fund I Limited, Mauritius

277500

Emerging India Fund, India

235370

Total

10917519

 

As on 21.08.2014

 

Equity Share Break up (Percentage of Total Equity)

 

Category

Percentage

Foreign holdings( Foreign institutional investor(s), Foreign companie(s) Foreign financial institution(s), Non-resident Indian(s) or Overseas Corporate bodies or Others

35.78

Bodies corporate

34.67

Directors or relatives of Directors

21.78

Other top fifty shareholders

7.77

Total

100.00

 

 

 

BUSINESS DETAILS

 

Line of Business :

Subject is engaged into providing diagnostic services.

 

 

Products / Services :

Product / Service Description

Item Code No. (ITC Code)

Diagnostic Service

99931960

 

 

Brand Names :

Not Available

 

 

Agencies Held :

Not Available

 

 

Exports :

Not Available

 

 

Imports :

 

Products:

Instruments

Countries :

Singapore                                                                                                                                                                                                                                                                                                            

 

 

Terms :

 

Selling :

Cash and Credit (30/60/90 Days)

 

 

Purchasing :

Cash and Credit (30/60/90 Days)

 

PRODUCTION STATUS = NOT AVAILABLE

 

 

GENERAL INFORMATION

 

Suppliers :

Reference :

Not Divulged

Name of the Person :

Not Divulged

Contact No.:

Not Divulged

Since How Long Known :

Not Divulged

Experience :

Not Divulged

Maximum Limit Dealt :

Not Divulged

 

 

Customers :

End Users and OEMs

Reference :

Not Divulged

Name of the Person :

Not Divulged

Contact No.:

Not Divulged

Since How Long Known :

Not Divulged

Experience :

Not Divulged

Maximum Limit Dealt :

Not Divulged

 

 

No. of Employees :

1000 (Approximately)

 

 

Bankers :

Banker Name

Axis Bank Limited

Branch Address

Naupada, Thane – 400802, Maharashtra, India

Person Name (With Designation)

Not Available

Contact Number

91-22-66905300 (Ringing)

Name of Account Holder

Not Available

Account Number

Not Available

Account Since (Date/Year of Account Opening)

Not Available

Average Balance Maintained (If Possible)

Not Available

Credit Facilities Enjoyed (If any)

Not Available

Account Operation

Not Available

Remarks (If any)

Not Available

 

Auditors :

 

Name :

B S R and Company

Chartered Accountants

Address :

1st Floor, Lodha Excelus, Appolo Mills Compound, N M Joshi Marg, Mahalaxmi,

Mumbai – 400011, Maharashtra, India

PAN No.:

AAIFB4734C

 

 

Memberships :

Not Available

 

 

Collaborators :

Not Available

 

 

Associates :

  • Nueclear Healthcare Limited, India
  • Sumathi Infra Projects Private Limited, India
  • Thyrocare International Holding Company Limited, Mauritius
  • Thyrocare Gulf Laboratories WLL, Bangladesh

 

 

CAPITAL STRUCTURE

 

After 21.08.2014

 

Authorised Capital: Rs.1000.000 Million

 

Issued, Subscribed & Paid-up Capital: Rs. 505.360 Million

 

 

As on 21.08.2014

 

Authorised Capital:

No. of Shares

Type

Value

Amount

 

 

 

 

100000000

Equity Shares

Rs.10/- each

Rs.1000.000 Million

 

Issued, Subscribed & Paid-up Capital:

No. of Shares

Type

Value

Amount

 

 

 

 

10917519

Equity Shares

Rs.10/- each

Rs.109.180 Million

 


 

FINANCIAL DATA

[all figures are in Rupees Million]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

31.03.2014

31.03.2013

31.03.2012

 

 

 

 

I.              EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

109.180

109.180

108.090

(b) Reserves & Surplus

1954.160

1496.470

923.900

(c) Money received against share warrants

0.000

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

0.000

0.000

0.000

Total Shareholders’ Funds (1) + (2)

2063.340

1605.650

1031.990

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) long-term borrowings

250.000

250.000

250.000

(b) Deferred tax liabilities (Net)

7.540

3.250

0.000

(c) Other long term liabilities

59.120

64.080

52.790

(d) long-term provisions

5.630

3.590

3.240

Total Non-current Liabilities (3)

322.290

320.920

306.030

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

0.000

0.000

0.000

(b) Trade payables

15.140

2.050

6.570

(c) Other current liabilities

50.780

25.880

6.130

(d) Short-term provisions

3.260

10.140

9.350

Total Current Liabilities (4)

69.180

38.070

22.050

 

 

 

 

TOTAL

2454.810

1964.640

1360.070

 

 

 

 

II.          ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

864.680

742.200

190.520

(ii) Intangible Assets

8.580

7.920

5.830

(iii) Capital work-in-progress

64.350

104.610

0.000

(iv) Intangible assets under development

176.150

176.150

240.000

(b) Non-current Investments

0.000

0.000

0.350

(c) Deferred tax assets (net)

53.570

53.260

36.230

(d)  Long-term Loan and Advances

0.000

0.000

0.000

(e) Other Non-current assets

0.000

0.000

0.000

Total Non-Current Assets

1167.330

1084.140

472.930

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

1013.930

596.030

0.000

(b) Inventories

62.920

52.430

50.950

(c) Trade receivables

49.060

33.330

23.680

(d) Cash and cash equivalents

119.020

175.300

590.310

(e) Short-term loans and advances

42.550

22.410

219.050

(f) Other current assets

0.000

1.000

3.150

Total Current Assets

1287.480

880.500

887.140

 

 

 

 

TOTAL

2454.810

1964.640

1360.070

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.03.2014

31.03.2013

31.03.2012

 

SALES

 

 

 

 

Income

1499.780

1342.610

1090.770

 

Other Income

59.160

176.800

54.580

 

TOTAL

1558.940

1519.410

1145.350

 

 

 

 

 

Less

EXPENSES

 

 

 

 

Cost of Materials Consumed

362.100

296.730

237.990

 

Purchases of Stock-in-Trade

63.960

59.600

49.060

 

Changes in inventories of finished goods, work-in-progress and Stock-in-Trade

(0.960)

(0.430)

3.620

 

Employees benefits expense

117.460

89.280

69.480

 

Other expenses

266.970

261.810

240.020

 

TOTAL

809.530

706.990

600.170

 

 

 

 

 

Less

PROFIT/ (LOSS)  BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION

749.410

812.420

545.180

 

 

 

 

 

Less

FINANCIAL EXPENSES

0.000

0.000

0.000

 

 

 

 

 

 

PROFIT / (LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION

749.410

812.420

545.180

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION

63.620

33.160

20.910

 

 

 

 

 

 

PROFIT/ (LOSS)  BEFORE TAX

685.790

779.260

524.270

 

 

 

 

 

Less

TAX

228.120

213.720

174.090

 

 

 

 

 

 

PROFIT/ (LOSS)  AFTER TAX 

457.670

565.540

350.180

 

 

 

 

 

 

EARNINGS IN FOREIGN CURRENCY

 

 

 

 

Export Sales

5.230

NA

NA

 

Testing & Processing Charges

7.800

NA

NA

 

Technical Assistance/Trade Mark Assignment Fees

2.520

NA

NA

 

TOTAL EARNINGS

15.550

NA

NA

 

 

 

 

 

 

IMPORTS

 

 

 

 

Raw Materials

2.710

1.730

0.350

 

Capital Goods

14.010

11.080

0.500

 

Spare Parts

0.000

0.000

0.490

 

TOTAL IMPORTS

16.720

12.810

1.340

 

 

 

 

 

 

Earnings / (Loss) Per Share (Rs.)

 

 

 

 

Basic

41.92

52.28

32.40

 

Diluted

36.83

45.88

28.43

 

Particulars

 

 

 

31.03.2015

Sales Turnover (Approximately)

 

 

1600.000

 

The above information has been parted by Mr. Aditya Shinde (Account Manager).

 

 

CURRENT MATURITIES OF LONG TERM DEBT DETAILS

 

Particulars

 

31.03.2014

31.03.2013

31.03.2012

Current Maturities of Long term debt

NA

NA

NA

Cash generated from operations

NA

NA

NA

Net cash flows from (used in) operations

694.650

687.540

532.810

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2014

31.03.2013

31.03.2012

Net Profit Margin

(PAT/Sales)

(%)

30.52

42.12

32.10

 

 

 

 

 

Operating Profit Margin

(PBDIT / Sales)

(%)

49.97

60.51

49.98

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

31.74

47.79

48.39

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.33

0.49

0.51

 

 

 

 

 

Debt Equity Ratio

(Total Debt/Networth)

 

0.12

0.16

0.24

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

18.61

23.13

40.23

 

 

FINANCIAL ANALYSIS

[all figures are in Rupees Million]

 

DEBT EQUITY RATIO

 

Particular

31.03.2012

31.03.2013

31.03.2014

 

(Rs. In Million)

(Rs. In Million)

(Rs. In Million)

Share Capital

108.090

109.180

109.180

Reserves & Surplus

923.900

1496.470

1954.160

Net worth

1031.990

1605.650

2063.340

 

 

 

 

long-term borrowings

250.000

250.000

250.000

Short term borrowings

0.000

0.000

0.000

Total borrowings

250.000

250.000

250.000

Debt/Equity ratio

0.242

0.156

0.121

 

 

 

YEAR-ON-YEAR GROWTH

 

Year on Year Growth

31.03.2012

31.03.2013

31.03.2014

 

(Rs. In Million)

(Rs. In Million)

(Rs. In Million)

Sales

1090.770

1342.610

1499.780

 

 

23.088

11.706

 

 

 

NET PROFIT MARGIN

 

Net Profit Margin

31.03.2012

31.03.2013

31.03.2014

 

(Rs. In Million)

(Rs. In Million)

(Rs. In Million)

Sales

1090.770

1342.610

1499.780

Profit

350.180

565.540

457.670

 

32.10%

42.12%

30.52%

 


 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check list by info agents

Available in Report (Yes/No)

1

Year of establishment

Yes

2

Constitution of the entity -Incorporation details

Yes

3

Locality of the entity

Yes

4

Premises details

Yes

5

Buyer visit details

----------------------

6

Contact numbers

Yes

7

Name of the person contacted

Yes

8

Designation of contact person

Yes

9

Promoter’s background

Yes

10

Date of Birth of Proprietor / Partners / Directors

Yes

11

Pan Card No. of Proprietor / Partners

No

12

Voter Id Card No. of Proprietor / Partners

No

13

Type of business

Yes

14

Line of Business

Yes

15

Export/import details (if applicable)

Yes

16

No. of employees

Yes

17

Details of sister concerns

Yes

18

Major suppliers

No

19

Major customers

No

20

Banking Details

Yes

21

Banking facility details

No

22

Conduct of the banking account

----------------------

23

Financials, if provided

Yes

24

Capital in the business

Yes

25

Last accounts filed at ROC, if applicable

Yes

26

Turnover of firm for last four years

Yes

27

Reasons for variation <> 20%

----------------------

28

Estimation for coming financial year

No

29

Profitability for last three years

Yes

30

Major shareholders, if available

Yes

31

External Agency Rating, if available

No

32

Litigations that the firm/promoter involved in

----------------------

33

Market information

----------------------

34

Payments terms

Yes

35

Negative Reporting by Auditors in the Annual Report

No

 

 

FINANCIAL RESULTS

 

For the financial year ended March 31, 2014, the Company has recorded revenue from operations at Rs. 1462.81 million was higher by 11.88% over last year (Rs. 1307.51 million in 2012-2013). The earnings before interest, tax, depreciation and amortization (EBITDA) was at Rs. 749.42 million as compared to Rs. 812.42 million in the previous year. The profit after tax (PAT) was at Rs. 457.67 million as compared to Rs. 565.54 million in the previous year.

 

 

COMPANY’S PERFORMANCE AND FUTURE OUTLOOK

 

Thyrocare today stands as a pioneer and leader in most of the diagnostic segments it operates. Not many imagined that a lab that did not look impressive, did not have any automation in 1996, did not do anything beyond Thyroid, did not do any technology other than Radioimmunoassay’s, would become industry leader in 2014. It is their single laboratory model for a Billion population, an adamant, undiluted single location philosophy proved its capability to control single handedly the cost of Thyroid in this country. Though today They have 1000 plus analysers standing in the country, competing with them in speed and rates, it is their quality, their brand, their name that brings specimen to one more machine in their floor and that says, brands are ruling and will continue to rule. Competition, no doubt has brought down their growth but their profitability give room for them to become more aggressive. It is more business, more competition, more decibels and of course, more motivating.

 

There will be an equilibrium well set between quality, reliability and reproducibility or peace of mind that branded national laboratories can offer, would get an additional growth for branded players consistently compared to market CAGR, although cost and speed may not be in their favor. Thyrocare has comforts to match both quality of national brand and cost of local unbranded so that in long run common man would continue get equally good solutions like rich man.

 

World’s largest preventive care laboratory and World’s largest Thyroid testing laboratory deserves World’s largest track automation. It is certainly a driver for their confidence and that of their client’s confidence in handling 100,000 specimen a night. It now occupies floor and improves their Turnaround time and enhances employee comforts. Introduction of Aarogyam profiles or introducing 6 part differentials of Sysmex in the floor or adding to the arsenal Molecular spectroscopy (ICP MS, LC MSMS) have differentiated them from conventional pathology laboratory. Their initiative in making vitamin profiles, Steroid profiles, Toxic element profiles and nutrient element profiles promise our growth curve enjoying their benefits for entire decade to come.

 

They are in more than a dozen countries now and are moving towards becoming largest preventive care laboratory in Bahrain which caters to 10 countries and Bangladesh. The floor is already performing and market is yet to be conquered. For the first two years of road, they are doing fairly well to take on the market in long run. It is biochemistry that 50,000 labs in India can do that they also do. But it is immunochemistry that only 5000 laboratories in India can do, in which they are already largest in the country and world, this includes Thyroid testing too. Our current focus is Analytical chemistry which ICPMS and LCMS are steering ahead and soon they would be in Nuclear Chemistry that would give edge to stand as a support when they reach the league of top 10 in the world in market capitalization

 

It is this young (mean age of 24), energetic, dynamic and most motivated manpower that would differentiate them from other players and it is important for them to mention that They had same mean age in 1995, 2000, 2005, 2010 and now in 2015. Company intends to double its manpower every year for next 5 years and that could make them to handle this Billion population with relative ease while they manage another billion outside India parallel.

 

 

UNSECURED LOAN

(Rs. In Million)

Particulars

As on

31.03.2014

As on

31.03.2013

LONG TERM BORROWING

 

 

Bonds / Debentures

250.000

250.000

Total

250.000

250.000

 

 

INDEX OF CHARGES: NO CHARGES EXIST FOR THE COMPANY

 

 

FIXED ASSETS

 

  • Land
  • Buildings
  • Plant and equipment
  • Furniture and fixtures
  • Vehicles
  • Office equipment

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration:

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration:

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime:

            Charges or conviction registered against subject:                                                                       None

 

5]         Records on Violation of Anti-Corruption Laws:

            Charges or investigation registered against subject:                                                        None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards:

            Charges or investigation registered against subject:                                                        None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government:

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package:

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report:

            No press reports / filings exists on the subject.

 


 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.66.81

UK Pound

1

Rs.100.36

Euro

1

Rs.70.68

 

 

INFORMATION DETAILS

 

Information Gathered by :

PPT

 

 

Analysis Done by :

KIN

 

 

Report Prepared by :

PNM


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

6

PAID-UP CAPITAL

1~10

5

OPERATING SCALE

1~10

6

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

6

--PROFITABILITY 

1~10

6

--LIQUIDITY

1~10

5

--LEVERAGE

1~10

6

--RESERVES

1~10

6

--CREDIT LINES

1~10

5

--MARGINS

-5~5

---

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

DEFAULTER

 

 

--RBI

YES/NO

NO

--EPF

YES/NO

NO

TOTAL

 

51

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

                                       New Business

 

--

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.